Shannon Heaning, Content Associate

Day 2 explored infectious disease, challenging diagnoses, GLP-1s in psoriasis, and evolving approaches to inflammatory skin disease.

From prevention and early detection to immunotherapy and radiation, revisit key takeaways from the Cutaneous Oncology Workshop.

Stay ahead with a weekly roundup of the biggest practice management, AI, policy, business, and professional development updates in dermatology.

Day 1 of Maui Derm NP+PA Fall 2026 highlighted emerging therapies, cutaneous oncology, challenging dermatitis cases, and procedural pearls.

Chantel Hillstead, a board-certified dermatology nurse practitioner, discussed how patients with hidradenitis suppurativa can prepare for unpredictable flares.

Maui Derm NP+PA Fall 2026 brings dermatology NPs and PAs together for clinical updates, interactive cases, and practical treatment discussions.

A seemingly benign pigmented lesion reveals a more complex diagnosis after deeper evaluation and molecular testing

A patient with moderate-to-severe plaque psoriasis has improved on treatment—but persistent plaques, itch, and frustration leave him wanting more. How would you approach the next step?

Two small clinical studies evaluated skincare and dermabrasion for changes in skin quality among individuals taking medical weight loss medications.

Two-year POETYK PsA-2 data showed sustained ACR and minimal disease activity responses with deucravacitinib and no new safety signals.

Faculty from the Cutaneous Oncology Workshop answer practical questions spanning skin cancer prevention, diagnosis, treatment, and follow-up.

Two new Neutrogena facial sunscreens incorporate bemotrizinol, the first new sunscreen active ingredient added to the US OTC monograph in decades.

Longer treatment duration was independently associated with VASI improvement, while publicly insured patients experienced higher topical JAK inhibitor denial rates.

Dermatology Times and Physicians' Education Resource will host DermNexus Congress, a two-day CME program for nurse practitioners and physician assistants, November 20–21 in Scottsdale, Arizona.

James Caleb Runyon, MSN, NP-C, shared lessons on building an advocacy initiative, developing partnerships, and balancing advocacy with clinical practice.

Amit Om, MD, discussed Mohs surgery, its high cure rates, patient education, and the importance of collaboration across dermatology care teams.

An HS toolbox with wound care, symptom relief, and personal care supplies can help patients stay prepared for unexpected flares.

The inaugural workshop explored skin cancer care from prevention and diagnosis through systemic therapy, radiation, and multidisciplinary management.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

The expanded indication makes Ameluz with RhodoLED the first FDA-approved photodynamic therapy for the treatment of a skin cancer.

Takeda’s investigational oral TYK2 inhibitor is supported by phase 3 LATITUDE data demonstrating significant skin clearance versus placebo and apremilast.

The final session of the Cutaneous Oncology Workshop explored advances in systemic therapy, management of immunotherapy-related skin reactions, and the role of radiation.

Attendees put technique into practice during an interactive suturing session led by Tristan Hasbargen, PA-C, using individual kits and real-world clinical examples.

At the Cutaneous Oncology Workshop, faculty explored lesion recognition, surgical decision-making, risk stratification, and the evolving role of molecular testing.

Faculty at the Dermatology Times Cutaneous Oncology Workshop addressed real-world questions on mole mapping, biopsy decisions, oral photoprotection, and actinic keratosis treatment.

In the morning session, Experts highlighted evolving photoprotection strategies, field-directed treatment of actinic keratoses, hereditary cancer risk, and practical dermoscopy pearls for APPs.

Dermatology Times kicks off its first Cutaneous Oncology Workshop, bringing APPs and experts together for practical skin cancer education.

Isotretinoin Effect on Adult Height in Danish Cohort Study

Twenty-five years after September 11, Dermatology Times reflects on the burn injuries, skin conditions, and clinicians who cared for survivors.

Dietary modification may improve disease activity and quality of life in some patients with chronic idiopathic urticaria.